Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
| Autor: | Zakarya, Kunsulu, Kutumbetov, Lespek, Orynbayev, Mukhit, Abduraimov, Yergali, Sultankulova, Kulyaisan, Kassenov, Markhabat, Sarsenbayeva, Gulbanu, Kulmagambetov, Ilyas, Davlyatshin, Timur, Sergeeva, Maria, Stukova, Marina, Khairullin, Berik |
|---|---|
| Zdroj: | In EClinicalMedicine September 2021 39 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|